Abiopharma

🔍 Uchida T Christopher (Executive)

Company: Palomar Holdings, Inc. (PLMR)

Report Date: 2026-08-18

Detailed Transactions and Holdings:

• Acquired 1,530 shares of Common Stock (Direct)
  Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 17,029.00 | transaction_form_type: 4
• Sold 791 shares of Common Stock at $127.741 per share (Direct)
  Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 16,238.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,530 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 1,530.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Represents shares automatically sold by the Company on behalf of the Reporting Person pursuant to a mandatory sell-to-cover provision in the RSU award agreement required to cover minimum statutory tax withholding obligations that became due upon the RSU vesting event.
• F2: The original RSU grant was for 30,594 shares on 11/18/2021. Subject to continuing service with the Company, the restricted stock units shall vest as follows: 6,118 units shall vest on the first year anniversary of the date of the grant; 6,118 units shall vest on the second year anniversary of the date of the grant; 6,118 units shall vest on the third year anniversary of the date of grant; and 1,530 units shall vest quarterly following the third anniversary date of the grant. These vesting terms reflect updates from the vesting terms stated on the original form 4, filed November 18, 2021, due to erroneous vesting terms being stated on the original form 4.